All Stories

  1. Age at First Osteoporosis Screening Among Older Women and Men: Is Bone Mineral Density Measurement Ordered Timely?

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, December 2018, Bentham Science Publishers

    Professor ILKER TASCI

  2. Assessment of geriatric predictors of adherence to Zoledronic acid treatment for osteoporosis: a prospective follow-up study

    Article • Acta Clinica Belgica, December 2017, Taylor & Francis

    Professor ILKER TASCI

  3. Undetected Peripheral Arterial Disease Among Older Adults With Alzheimer’s Disease and Other Dementias

    Article • American Journal of Alzheimer s Disease & Other Dementias®, August 2017, SAGE Publications

    Professor ILKER TASCI

  4. Computerized Tomography–based Diagnosis of Sarcopenia?

    Article • Annals of Surgery, January 2016, Wolters Kluwer Health

    Professor ILKER TASCI

  5. Comment on “Metabolic Syndrome and Elevated C-Reactive Protein Levels in Elderly Patients With Newly Diagnosed Depression”

    Article • Psychosomatics, March 2015, Elsevier

    Professor ILKER TASCI

  6. A New Combination Therapy in Severe Acute Pancreatitis—Hyperbaric Oxygen Plus 3-Aminobenzamide

    Article • Pancreas, March 2015, Wolters Kluwer Health

    Professor ILKER TASCI

  7. Insulin vs Sulfonylureas for Second-Line Diabetes Treatment

    Article • JAMA, October 2014, American Medical Association (AMA)

    Professor ILKER TASCI

  8. Comment on “Lower lean mass and higher percent fat mass in patients with Alzheimer's disease”

    Article • Experimental Gerontology, October 2014, Elsevier

    Professor ILKER TASCI

  9. Nutrition interventions in bed rest trials

    Article • Journal of Applied Physiology, September 2014, American Physiological Society

    Professor ILKER TASCI

  10. Sarcopenia is more than simply documenting low skeletal muscle mass

    Article • Cancer, September 2014, Wiley

    Professor ILKER TASCI

  11. Bioimpedance analysis—The shortcomings

    Article • Obesity Research & Clinical Practice, July 2014, Elsevier

    Professor ILKER TASCI

  12. P2‐391: SLEEP STATUS IN DEMENTIA PATIENTS: A NOVEL TARGET FOR CHOICES OF CHOLINESTERASE INHIBITORS?

    Article • Alzheimer s & Dementia, July 2014, Wiley

    Professor ILKER TASCI

  13. Effects of valsartan treatment on serum ghrelin level and left ventricular mass index in patients with untreated primary hypertension

    Article • Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology, June 2014, Kare Publishing

    Professor ILKER TASCI

  14. Home-Based Exercise and Hip Fracture Rehabilitation

    Article • JAMA, June 2014, American Medical Association (AMA)

    Professor ILKER TASCI

  15. Comment on “Sarcopenic Obesity and Risk of Cardiovascular Disease and Mortality: A Population‐Based Cohort Study of Older Men”

    Article • Journal of the American Geriatrics Society, June 2014, Wiley

    Professor ILKER TASCI

  16. Increased Calcaneal Spur Frequency in Patients with Obesity and Type-2 Diabetes Mellitus

    Article • Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, May 2014, Baycinar Tibbi Yayincilik

    Professor ILKER TASCI

  17. Re. Pre- and perioperative factors affecting infection after living donor liver transplantation

    Article • Nutrition, February 2014, Elsevier

    Professor ILKER TASCI

  18. Influences of Treatment with Amlodipine and Valsartan on Bone Turnover Markers and OPG/RANKL/RANK System in Newly Diagnosed Hypertensive Adults; Which is more Beneficial?

    Article • Turkish Nephrology Dialysis Transplantation, January 2014, Turkish Nephrology Dialysis Transplantation

    Professor ILKER TASCI

  19. Depression and anxiety disorders among gastroenterologic outpatients

    Article • Saudi Journal of Gastroenterology, January 2014, Medknow

    Professor ILKER TASCI

  20. Is segmental bioelectrical impedance analysis a valid tool to assess muscle mass in the elderly?

    Article • Geriatrics and Gerontology International, October 2013, Wiley

    Professor ILKER TASCI

  21. Cognitive and Functional Influences of Vildagliptin, a DPP-4 Inhibitor, Added to Ongoing Metformin Therapy in Elderly with Type 2 Diabetes

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, October 2013, Bentham Science Publishers

    Professor ILKER TASCI

  22. Establishing exercise habit is important when assessing lean body mass in elderly

    Article • Clinical Nutrition, August 2013, Elsevier

    Professor ILKER TASCI

  23. Accurate diagnosis of sarcopenia in the elderly requires correct measurement of muscle mass

    Article • Clinical Nutrition, August 2013, Elsevier

    Professor ILKER TASCI

  24. P4–204: The association of hand grip strength, skeletal muscle mass, 5‐meter walking speed and bone mineral densitometry in a small population of Turkish elderly

    Article • Alzheimer s & Dementia, July 2013, Wiley

    Professor ILKER TASCI

  25. Comment on “Association of anorexia with sarcopenia in a community-dwelling elderly population: results from the ilSIRENTE study”

    Article • European Journal of Nutrition, June 2013, Springer Science + Business Media

    Professor ILKER TASCI

  26. Comment to “Age-related changes in body composition in a sample of Czech women aged 18–89 years: a cross-sectional study”

    Article • European Journal of Nutrition, June 2013, Springer Science + Business Media

    Professor ILKER TASCI

  27. Effects of three different medications on metabolic parameters and testicular volume in patients with hypogonadotropic hypogonadism: 3‐year experience

    Article • Clinical Endocrinology, May 2013, Wiley

    Professor ILKER TASCI

  28. Görme ve Kas Gücü Kaybı ile Gelen Bir POEMS Sendromu Olgusu

    Article • Türk Nöroloji Dergisi, March 2013, Journal of Clinical Research of Pediatric Endocrinology

    Professor ILKER TASCI

  29. Sarcoidosis and IgA nephropathy: a rare association

    Article • Respiratory Case Reports, January 2013, LookUs Bilisim, Ltd.

    Professor ILKER TASCI

  30. Ankle brachial index as a predictor of subclinical atherosclerosis in the elderly

    Article • International Journal of Cardiology, October 2012, Elsevier

    Professor ILKER TASCI

  31. Brain derived neurotrophic factor (BDNF) in cardiometabolic physiology and diseases

    Article • Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology, September 2012, Kare Publishing

    Professor ILKER TASCI

  32. Atrial Fibrillation and the Hachinski Ischemic Scale

    Article • Archives of Neurology, August 2012, American Medical Association (AMA)

    Professor ILKER TASCI

  33. Cálculo do Índice Tornozelo-Braquial

    Article • Arquivos Brasileiros de Cardiologia, August 2012, FapUNIFESP (SciELO)

    Professor ILKER TASCI

  34. Increase in subcutaneous adipose tissue and fat free mass in women with polycystic ovary syndrome is related to impaired insulin sensitivity

    Article • Gynecological Endocrinology, July 2012, Taylor & Francis

    Professor ILKER TASCI

  35. Letter to the Editor

    Article • Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology, July 2012, Kare Publishing

    Professor ILKER TASCI

  36. Ankle-brachial Index, Peripheral Arterial Disease, and Diabetic Retinopathy

    Article • Journal of Preventive Medicine and Public Health, March 2012, Korean Society for Preventive Medicine (KAMJE)

    Professor ILKER TASCI

  37. Diagnosing PAD by calculating the ankle brachial index: Adherence to the guidelines

    Article • Journal of Vascular Nursing, March 2012, Elsevier

    Professor ILKER TASCI

  38. High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome

    Article • Gynecological Endocrinology, February 2012, Taylor & Francis

    Professor ILKER TASCI

  39. Ankle–Brachial Index as an Indicator of Arterial Stiffness

    Article • Angiology, January 2012, SAGE Publications

    Professor ILKER TASCI

  40. Calculation Methods of Ankle Brachial Index and Correct Diagnosis of Peripheral Arterial Disease

    Article • Journal of Atherosclerosis and Thrombosis, January 2012, Japan Atherosclerosis Society

    Professor ILKER TASCI

  41. Very Low Frequency of PAD in People with CHD in Six Middle Eastern Countries

    Article • International Journal of Vascular Medicine, January 2012, Hindawi Publishing Corporation

    Professor ILKER TASCI

  42. Soluble CD40 ligand, soluble P-selectin and von Willebrand factor levels in subjects with prediabetes: The impact of metabolic syndrome

    Article • Clinical Biochemistry, January 2012, Elsevier

    Professor ILKER TASCI

  43. The relationship of epicardial adipose tissue thickness to clinical and biochemical features in women with polycystic ovary syndrome

    Article • Endocrine Journal, January 2012, Japan Endocrine Society

    Professor ILKER TASCI, Dr Baris Bugan

  44. Apelin, Prediabetes and Atherosclerosis

    Article • Experimental and Clinical Endocrinology & Diabetes, August 2011, Thieme Publishing Group

    Professor ILKER TASCI

  45. Oxidative stress, obstructive sleep apnea and cardiovascular disease

    Article • Sleep And Breathing, July 2011, Springer Science + Business Media

    Professor ILKER TASCI

  46. Do cardiovascular disease risk prediction tools need to be updated in Europe?

    Article • Internal and Emergency Medicine, June 2011, Springer Science + Business Media

    Professor ILKER TASCI

  47. Decreased small dense LDL levels in Gilbert's syndrome

    Article • Clinical Biochemistry, March 2011, Elsevier

    Professor ILKER TASCI

  48. Peripheral artery disease assessed by ankle-brachial index in patients with established cardiovascular disease or at least one risk factor for atherothrombosis - CAREFUL Study: A national, multi-center, cross-sectional observational study

    Article • BMC Cardiovascular Disorders, January 2011, Springer Science + Business Media

    Professor ILKER TASCI

  49. Coincidence of Membranous Glomerulonephritis and Autoimmune Thyroiditis: A Case Report

    Article • Turkish Nephrology Dialysis Transplantation, June 2010, Turkish Nephrology Dialysis Transplantation

    Professor ILKER TASCI

  50. Non-alcoholic fatty liver disease and adipocytokines

    Article • Liver International, May 2010, Wiley

    Professor ILKER TASCI

  51. Plasma Apelin and ADMA Levels in Patients with Essential Hypertension

    Article • Clinical and Experimental Hypertension, May 2010, Taylor & Francis

    Professor ILKER TASCI

  52. Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus

    Article • Endocrine, April 2010, Springer Science + Business Media

    Professor ILKER TASCI

  53. Clinical usefulness of AGEs as a biomarker for the attenuation of NASH

    Article • Journal of Gastroenterology, March 2010, Springer Science + Business Media

    Professor ILKER TASCI

  54. The relation of ADMA and apelin to endothelial dysfunction and angiogenesis in patients with type 2 diabetes mellitus

    Article • Diabetes Research and Clinical Practice, November 2009, Elsevier

    Professor ILKER TASCI

  55. Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: A link to protection against atherosclerosis?

    Article • Clinical Biochemistry, June 2009, Elsevier

    Professor ILKER TASCI

  56. Adipocytokine Levels in Chronic Pancreatitis

    Article • Pancreas, May 2009, Wolters Kluwer Health

    Professor ILKER TASCI

  57. P0077 INCIDENTAL DIAGNOSIS OF PEYRONIE DISEASE IN CASE WITH CARSINOID SYNDROME

    Article • European Journal of Internal Medicine, May 2009, Elsevier

    Professor ILKER TASCI

  58. LDL-cholesterol lowering increases plasma apelin in isolated hypercholesterolemia

    Article • Atherosclerosis, May 2009, Elsevier

    Professor ILKER TASCI, Professor Cengizhan ACIKEL

  59. NASH and Cardiovascular Biomarkers

    Article • Obesity, April 2009, Wiley

    Professor ILKER TASCI

  60. Adiponectin levels in patients undergoing coronary stenting

    Article • Clinical Biochemistry, April 2009, Elsevier

    Professor ILKER TASCI

  61. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients

    Article • Nutrition, February 2009, Elsevier

    Professor ILKER TASCI

  62. Orlistat for overweight subjects with nonalcoholic steatohepatitis

    Article • Hepatology, January 2009, Wolters Kluwer Health

    Professor ILKER TASCI

  63. Hepatic steatosis, visceral adiposity, insulin resistance, adiponectin, and inflammation

    Article • Metabolism, January 2009, Elsevier

    Professor ILKER TASCI

  64. Serum adipokine levels in the obese people

    Article • International Journal of Biological Sciences, January 2009, Ivyspring International Publisher

    Professor ILKER TASCI

  65. Rosiglitazone for Nonalcoholic Steatohepatitis

    Article • Gastroenterology, December 2008, Elsevier

    Professor ILKER TASCI

  66. Ewing’s sarcoma of the fibula presenting with venous thrombosis

    Article • Clinical & Translational Oncology, December 2008, Springer Science + Business Media

    Professor ILKER TASCI

  67. Asymmetric dimethylarginine levels decrease because of insulin infusion: is it an unexpected finding?

    Article • Metabolism, November 2008, Elsevier

    Professor ILKER TASCI

  68. The effects of pioglitazone and metformin on plasma visfatin levels in patients with treatment naive type 2 diabetes mellitus

    Article • Diabetes Research and Clinical Practice, November 2008, Elsevier

    Professor ILKER TASCI

  69. Nonalcoholic steatohepatitis is frequently accompanied by metabolic diseases

    Article • Hepatology, October 2008, Wolters Kluwer Health

    Professor ILKER TASCI

  70. Adipokines and cytokines in non‐alcoholic fatty liver disease

    Article • Alimentary Pharmacology & Therapeutics, June 2008, Wiley

    Professor ILKER TASCI

  71. Metabolic Syndrome is Related to Nonalcoholic Steatohepatitis in Severely Obese Subjects

    Article • Obesity Surgery, June 2008, Springer Science + Business Media

    Professor ILKER TASCI

  72. Ultrastructural changes in hepatocytes after taurine treatment in CCl4 induced liver injury

    Article • World Journal of Gastroenterology, January 2008, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor ILKER TASCI

  73. Maprotiline induced weight gain in depressive disorder: Changes in circulating ghrelin and adiponectin levels and insulin sensitivity

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, January 2008, Elsevier

    Professor ILKER TASCI

  74. Allopurinol in Rat Chronic Pancreatitis

    Article • Pancreas, November 2007, Wolters Kluwer Health

    Professor Ahmet Turan ISIK, Professor ILKER TASCI

  75. Tegaserod-Related Possible Drug Interactions

    Article • The American Journal of Gastroenterology, June 2007, Wolters Kluwer Health

    Professor ILKER TASCI

  76. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance

    Article • Diabetes Research and Clinical Practice, April 2007, Elsevier

    Professor ILKER TASCI

  77. Platelet Aggregation is not Enhanced in Patients with Prediabetes

    Article • Upsala Journal of Medical Sciences, January 2007, Uppsala Medical Society

    Professor ILKER TASCI

  78. Antioxidant Treatment with Taurine Ameliorates Chronic Pancreatitis in an Experimental Rat Model

    Article • Pancreas, July 2006, Wolters Kluwer Health

    Professor Ahmet Turan ISIK, Professor ILKER TASCI

  79. The effect of fluvastatin on plasma adiponectin levels in dyslipidaemia

    Article • Clinical Endocrinology, April 2006, Wiley

    Professor ILKER TASCI

  80. Adiponectin and Insulin Resistance in Young and Healthy Smokers

    Article • Endocrine Journal, January 2006, Japan Endocrine Society

    Professor ILKER TASCI

  81. Plasma Adiponectin and Insulin Resistance in New Onset Hypertension

    Article • Endocrine, January 2006, Springer Science + Business Media

    Professor ILKER TASCI

  82. Soluble CD40 Ligand Levels in Otherwise Healthy Subjects With Impaired Fasting Glucose

    Article • Mediators of Inflammation, January 2006, Hindawi Publishing Corporation

    Professor ILKER TASCI

  83. Hyperbaric oxygen-induced changes in bacterial translocation and acinar ultrastructure in rat acute necrotizing pancreatitis

    Article • Journal of Gastroenterology, October 2005, Springer Science + Business Media

    Professor Ahmet Turan ISIK, Professor ILKER TASCI

  84. Panic Attack Precipitated by Tegaserod plus Fluoxetine

    Article • Clinical Drug Investigation, January 2005, Springer Science + Business Media

    Professor ILKER TASCI

  85. The Effect of Combination Therapy of Hyperbaric Oxygen, Meropenem, and Selective Nitric Oxide Synthase Inhibitor in Experimental Acute Pancreatitis

    Article • Pancreas, January 2004, Wolters Kluwer Health

    Professor Ahmet Turan ISIK, Professor ILKER TASCI

  86. Deferoxamine and Meropenem Combination Therapy in Experimental Acute Pancreatitis

    Article • Pancreas, October 2003, Wolters Kluwer Health

    Professor ILKER TASCI